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Introduction: Most individuals infected with human immunodeficiency virus-1, in the absence of antiretroviral
therapy, exhibit persistent virus replication and declining CD4+ cell numbers, and progress to acquired
immunodeficiency syndrome within 10 years of infection. Elite controllers are rare individuals with human
immunodeficiency virus-1 infection who can maintain undetectable plasma virus levels and remain asymptomatic
without antiretroviral therapy. It has been proposed that elite controllers benefit from being infected with
attenuated human immunodeficiency virus-1 variants.
Case presentation: A 31-year-old African woman presented with human immunodeficiency virus-1 infection
during pregnancy and was diagnosed with acquired immunodeficiency syndrome. Subsequently, her husband, a
31-year-old African man, was tested and found to be seropositive for human immunodeficiency virus-1. His plasma
human immunodeficiency virus-1 ribonucleic acid level was found to be below the limit of detection of the clinical
assay.
Conclusion: This report provides evidence for the first described case of human immunodeficiency virus-1 infection
possibly transmitted from an elite controller to a patient who progressed to acquired immunodeficiency syndrome.
This observation strengthens the case against avirulence as a mechanism that protects elite controllers.Introduction
Most individuals with human immunodeficiency virus-1
(HIV-1) infection who are untreated have plasma viral
loads that exceed 1000 HIV-1 ribonucleic acid (RNA)
copies/mL and they progress to acquired immunodefi-
ciency syndrome (AIDS) within 10 years of infection [1].
Some people infected with HIV-1 maintain undetectable
viral loads for years, and can remain asymptomatic for
indefinite periods of time (>20 years) [2]; these indivi-
duals are known as elite controllers (ECs). The biologic
mechanism(s) for their remarkable control of HIV-1 rep-
lication has not been determined [3]. The transmission
of HIV-1 infection from a patient with AIDS to an EC
has been documented [4]. This finding was not* Correspondence: m.scott.killian@gmail.com
1Department of Medicine, University of California San Francisco, 513
Parnassus Avenue, Box 1270, San Francisco, CA 94143, USA
Full list of author information is available at the end of the article
© 2012 Killian et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orunexpected as HIV-1 infection is most likely to be trans-
mitted by individuals having high viral loads, such as
those with untreated AIDS [5-7]. Here, we provide evi-
dence for a possible reciprocal case of HIV-1 transmitted
from an EC to a patient who then progressed to AIDS.
Case presentation
Patient FF presented as a 31-year-old pregnant woman
from Johannesburg, who was tested for HIV and found
to be HIV-1 seropositive 24 hours before delivery by
Caesarean section in 2001. At that time, she was
promptly given a dose of nevirapine to prevent perinatal
transmission. Further clinical and laboratory testing
revealed that FF had AIDS. Her peripheral blood cluster
of differentiation CD4+ cell count was 61cells/μL (7%)
and her plasma viral load was 51,700 HIV-1 RNA cop-
ies/mL. She had florid oral candidiasis and was emaci-
ated. Since initiating combination antiretroviral therapytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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viral load has reached an undetectable level (<20 HIV-1
RNA copies/mL) and her CD4+ cell count has
rebounded to 435 cells/μL. FF confirmed that, prior to
her marriage to her husband (MM) in 2000, she had
tested negative for HIV-1 during a previous pregnancy
and that child, from a previous partner, was also negative
for the virus. That child was breastfed by FF for at least
12 months and remained uninfected. Our patient
reported that since 2000, her husband is the only partner
with whom she has had sexual contact.
Patient MM, the husband of FF, presented as a 31-year-
old man for HIV-1 testing soon after his wife was found
to be HIV-1 seropositive. In an interview, MM stated that
he had been monogamous in his marital relationship with
FF and that he had no prior sexual partners. MM gave no
history of any infectious diseases but had undergone sur-
gery three years previously for treatment of an abdominal
gunshot wound. He reported having received a blood
transfusion in association with that surgery. At that time
in South Africa, the screening for HIV-1 contamination of
blood for transfusion was not as thorough as present stan-
dards (polymerase chain reaction (PCR)-based screening
of blood for HIV-1 contamination was being newly imple-
mented in South Africa in 2000; GNV, independent obser-
vation). On examination, MM was found to be generally
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Figure 1 Longitudinal measurements of CD4+ cells and human immu
percentages and absolute counts were monitored in blood from patient M
virus-1 ribonucleic acid, deoxyribonucleic acid, and p24 levels and anti-hum
(+), positive test result; (-), negative test result; n.d., test not performed; HIV
reaction-ribonucleic acid; PCR-DNA, polymerase chain reaction-deoxyribonubeing normal. MM was found to be HIV-1 seropositive by
Western blot. However, he had an undetectable plasma
viral load (<50 HIV-1 RNA copies/mL), his CD4+ T cell
count of 1123/μL (32%) was well within the normal range,
and his CD4+ T cell to CD8+ T cell ratio was not inverted.
In accordance with standard clinical guidelines at that
time, no antiretroviral treatment was initiated.
During a follow-up period of 10 years (Figure 1), MM
consistently maintained an undetectable (<50 HIV-1
RNA copies/mL) plasma viral load. Over this 10 year
period, MM tested negative for HIV-1 deoxyribonucleic
acid (DNA) by PCR on at least eight separate occasions.
His CD4+ cell counts (525 to 1123 cells/μL) and percen-
tages (31% to 40%) stayed in the normal range. He
remained asymptomatic, free of the opportunistic infec-
tions and cancers that characterize AIDS.
To compare their viruses, peripheral blood mono-
nuclear cells (PBMC) were isolated upon Ficoll gradient
separation of whole blood specimens that were collected
from MM and FF in 2008. Total nucleic acids (both
DNA and RNA) were extracted from the PBMC, and
HIV-1 sequences were reverse transcribed, amplified by
nested-PCR and then sequenced at Roche Molecular
Diagnostics (Pleasanton, CA, USA). Noteworthy is that
this successful effort to obtain HIV-1 DNA from MM
involved more intensive efforts (for example, isolation of
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nodeficiency virus-1 levels. During a period of 10 years, CD4+ cell
M. Also performed were measurements of human immunodeficiency
an immunodeficiency virus-1 antibodies. EIA, enzymatic immunoassay;
-1, human immunodeficiency virus-1; PCR-RNA, polymerase chain
cleic acid.
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standard procedures used for the qualitative HIV-1
DNA measurements shown in Figure 1.
Analyses were performed on a highly-conserved 255
base pair region of the HIV-1 gag (p24) gene (bases 1305
to 1559 in HXB2) (Figure 2). The gag sequences from
MM and FF (Figure 2A) were compared with other HIV-1
sequences in the Los Alamos HIV database [8]. Phylogen-
etic analysis revealed that both sequences clustered withB













































Figure 2 Analysis of the patients’ human immunodeficiency virus-1 s
immunodeficiency virus-1 gag gene was sequenced. (A) Shown are the nuc
consensus human immunodeficiency virus-1 clade C sequence. Standard am
immunodeficiency virus-1 gag sequences from MM and FF, along with 27 h
were aligned and then analyzed with the PhyML tool [8]. Shown is a phylog
immunodeficiency virus-1 clade B HXB2 gag sequence is included as an out
sequences. (C) The human immunodeficiency virus-1 gag sequence from M
viruses published in the Los Alamos human immunodeficiency virus-1 data
the published clade C sequences based on the number of nucleotides thatHIV-1 clade C viruses (data not shown), a subtype that
accounts for roughly half of the HIV infections worldwide
[9]. Using the maximum likelihood procedure [10], the
gag sequences of MM and FF were found to cluster to-
gether in comparison with 27 other HIV-1 clade C gag
sequences from South Africa (Figure 2B). In comparison
with the consensus HIV-1 clade C sequence, MM differed
at one of the 255 bases, while FF differed at six of the 255
bases. Importantly, the one difference in MM’s sequenceC
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equences. A highly-conserved 255 base pair region of the human
leotide sequences obtained from FF and MM, as compared with the
biguity codes are used (R =G or A; Y = T or C). (B) The human
uman immunodeficiency virus-1 clade C sequences from South Africa,
enetic tree made with the maximum likelihood method. The human
group. GenBank accession numbers are given for the comparison
M was compared with other human immunodeficiency virus-1 clade C
base using the QuickAlign tool [8]. Shown is a frequency histogram of
differ from the MM human immunodeficiency virus-1 gag sequence.
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from MM and FF differed at only five nucleotide positions.
Further analyses, performed using the QuickAlign tool in
the HIV database, revealed that the majority of published
clade C sequences differ from MM’s sequence in this re-
gion at greater than 10 of 255 nucleotides (Figure 2C).
Moreover, less than 1% of the 400 published clade C
viruses differed at six or fewer bases in this region. Even
fewer would be expected to share only the discrepant
nucleotide. These data demonstrate that the HIV-1
sequences from MM and FF are uniquely similar and
provide evidence for the possibility that HIV-1 was
transmitted between MM and FF.
Discussion
It has not been previously appreciated that ECs can
transmit HIV-1 infection. In this report, we present evi-
dence for the possible transmission of HIV-1 from an
EC to another individual. The primary evidence for this
event is the medical history of MM involving reasonable
risk for HIV-1 infection, the clinical history of FF, the
self-reported sexual histories of MM and FF, and com-
parisons of the HIV-1 sequences found in MM and FF.
A limitation of this case report is its reliance on self-
reported histories for risk of HIV-1 infection; we trust
that MM and FF have provided truthful HIV-risk histor-
ies. Thus, it remains possible that we are incorrect in our
assessment of the transmission history. Other scenarios
include the transmission of HIV-1 from FF to MM. This
sequence of events would discount the presumption that
MM was infected with HIV-1 upon blood transfusion,
but would allow for FF having a more typical AIDS-free
survival time [11]. Even so, phylogenic analyses cannot
prove that the transmission of HIV-1 occurred directly
between two individuals [12-14]. In this regard, prospect-
ive studies of HIV-1 transmission among sero-discordant
couples, with the partner infected with HIV-1 being an
EC, are needed.
We were not able to determine the clinical stage when
MM possibly transmitted HIV-1 to FF. Most cases of
HIV-1 infection are thought to be transmitted during
acute infection, a period of three to six weeks following
initial infection that features the highest viral loads of
any stage of HIV-1 infection [15]. Little is known about
acute HIV-1 infection in ECs and whether or not ECs
exhibit high viral loads at this stage remains to be deter-
mined. Nonetheless, the case we present raises the con-
cern that HIV-1 can possibly be transmitted in the
absence of detectable plasma virus levels.
Conclusions
This case study details evidence for the possible trans-
mission of HIV-1 infection from an EC to his wife.
Emphasized is that apathogenic HIV-1 in one individualcan cause typical disease in another. Efforts to control
the spread of HIV-1 infection should take into consider-
ation the potential roles of aviremic individuals in trans-
mitting the virus.
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